The Only H.I.V. Vaccine in Advanced Trials Has Failed. What Now?

The New York Times – Business:

Janssen Pharmaceuticals ended a global trial after independent experts determined the vaccine was not effective. But there are other possibilities in the pipeline, scientists said.

This post first appeared in The New York Times – Business. Read the original article.